Fastnet Securities 16 DAC
Fastnet Securities 16 DAC
05/03/2024 | Press release | Distributed by Public on 05/03/2024 05:22
AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
Fastnet Securities 16 DAC
05/03/2024 | Press release | Distributed by Public on 05/03/2024 05:22
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact